| scholarly article | Q13442814 |
| P2093 | author name string | Stuart A Sievers | |
| Magdalena I Ivanova | |||
| Michael R Sawaya | |||
| P John Hart | |||
| David S Eisenberg | |||
| Duane D Winkler | |||
| Lisa M Johnson | |||
| Ahmad Galaleldeen | |||
| Elizabeth L Guenther | |||
| P2860 | cites work | Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis | Q21136374 |
| Molecular basis for insulin fibril assembly | Q24657505 | ||
| Atomic structures of amyloid cross-beta spines reveal varied steric zippers | Q27644644 | ||
| Disrupted Zinc-Binding Sites in Structures of Pathogenic SOD1 Variants D124V and H80R | Q27662078 | ||
| Determination and analysis of the 2 A-structure of copper, zinc superoxide dismutase | Q27729237 | ||
| Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury | Q28511628 | ||
| Amyotrophic lateral sclerosis | Q29619516 | ||
| Mutation-dependent polymorphism of Cu,Zn-superoxide dismutase aggregates in the familial form of amyotrophic lateral sclerosis | Q33559556 | ||
| Identifying the amylome, proteins capable of forming amyloid-like fibrils | Q33734407 | ||
| Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis. | Q33772493 | ||
| Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients | Q33996210 | ||
| An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1 | Q34341120 | ||
| IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients | Q34351001 | ||
| Copper and zinc metallation status of copper-zinc superoxide dismutase from amyotrophic lateral sclerosis transgenic mice. | Q34509452 | ||
| Disulfide-reduced ALS variants of Cu, Zn superoxide dismutase exhibit increased populations of unfolded species | Q34788369 | ||
| Molecular biology of amyotrophic lateral sclerosis: insights from genetics | Q36573336 | ||
| Different regulation of wild-type and mutant Cu,Zn superoxide dismutase localization in mammalian mitochondria | Q36934610 | ||
| Initiation and elongation in fibrillation of ALS-linked superoxide dismutase | Q36978868 | ||
| Structural similarity of wild-type and ALS-mutant superoxide dismutase-1 fibrils using limited proteolysis and atomic force microscopy | Q36991027 | ||
| SOD1 aggregation and ALS: role of metallation states and disulfide status | Q38075887 | ||
| Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype. | Q39217852 | ||
| Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site | Q44070818 | ||
| Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature | Q44579313 | ||
| Familial amyotrophic lateral sclerosis with His46Arg mutation in Cu/Zn superoxide dismutase presenting characteristic clinical features and Lewy body-like hyaline inclusions | Q45090366 | ||
| Dissociation of human copper-zinc superoxide dismutase dimers using chaotrope and reductant. Insights into the molecular basis for dimer stability | Q45107835 | ||
| Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis | Q48355423 | ||
| Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis | Q73144671 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
| P304 | page(s) | 197-201 | |
| P577 | publication date | 2014-01-07 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALS | |
| P478 | volume | 111 |
| Q38734301 | A Phosphomimetic Mutation Stabilizes SOD1 and Rescues Cell Viability in the Context of an ALS-Associated Mutation |
| Q26775401 | A comprehensive review of amyotrophic lateral sclerosis |
| Q47741777 | A computational combinatorial approach identifies a protein inhibitor of superoxide dismutase 1 misfolding, aggregation, and cytotoxicity. |
| Q58621641 | Amyloid assembly and disassembly |
| Q45953477 | Atomic structure of a toxic, oligomeric segment of SOD1 linked to amyotrophic lateral sclerosis (ALS). |
| Q49907306 | Atomic structures of corkscrew-forming segments of SOD1 reveal varied oligomer conformations |
| Q57801718 | Copper signalling: causes and consequences |
| Q47568820 | Critical Nucleus Structure and Aggregation Mechanism of the C-terminal Fragment of Copper-Zinc Superoxide Dismutase Protein |
| Q47738138 | Cysteine to Serine Conversion at 111th Position Renders the Disaggregation and Retains the Stabilization of Detrimental SOD1 A4V Mutant Against Amyotrophic Lateral Sclerosis in Human-A Discrete Molecular Dynamics Study |
| Q91887225 | Differential Misfolding Properties of Glaucoma-Associated Olfactomedin Domains from Humans and Mice |
| Q40885460 | Dynamic properties of SOD1 mutants can predict survival time of patients carrying familial amyotrophic lateral sclerosis. |
| Q50993029 | Epigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis. |
| Q55407794 | Evaluation of variability in high-resolution protein structures by global distance scoring. |
| Q40433494 | Examination of Ataxin-3 (atx-3) Aggregation by Structural Mass Spectrometry Techniques: A Rationale for Expedited Aggregation upon Polyglutamine (polyQ) Expansion |
| Q64241123 | Experimental Mutations in Superoxide Dismutase 1 Provide Insight into Potential Mechanisms Involved in Aberrant Aggregation in Familial Amyotrophic Lateral Sclerosis |
| Q90019133 | Factor VIII exhibits chaperone-dependent and glucose-regulated reversible amyloid formation in the endoplasmic reticulum |
| Q90459885 | Friction-Limited Folding of Disulfide-Reduced Monomeric SOD1 |
| Q57840236 | Inhibitory effect of hydrophobic fullerenes on the β-sheet-rich oligomers of a hydrophilic GNNQQNY peptide revealed by atomistic simulations |
| Q34822175 | Kinetic Monte Carlo simulations of the assembly of filamentous biomacromolecules by dimer addition mechanism. |
| Q57829032 | Large SOD1 aggregates, unlike trimeric SOD1, do not impact cell viability in a model of amyotrophic lateral sclerosis |
| Q35588631 | Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model |
| Q58608539 | Loss of charge mutations in solvent exposed Lys residues of superoxide dismutase 1 do not induce inclusion formation in cultured cell models |
| Q47703808 | Lysine acylation in superoxide dismutase-1 electrostatically inhibits formation of fibrils with prion-like seeding |
| Q47839028 | MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALS. |
| Q58829079 | Modulating the Folding Landscape of Superoxide Dismutase 1 with Targeted Molecular Binders. |
| Q89976497 | Mutations in Superoxide Dismutase 1 (Sod1) Linked to Familial Amyotrophic Lateral Sclerosis Can Disrupt High-Affinity Zinc-Binding Promoted by the Copper Chaperone for Sod1 (Ccs) |
| Q30101060 | Parsing Disease-relevant Protein Modifications from Epiphenomena: Perspective on the Structural Basis of SOD1-Mediated ALS. |
| Q47550175 | Pathological hydrogen peroxide triggers the fibrillization of wild-type SOD1 via sulfenic acid modification of Cys-111. |
| Q52600838 | Poloxamer 188 decreases membrane toxicity of mutant SOD1 and ameliorates pathology observed in SOD1 mouse model for ALS. |
| Q42074999 | Protein charge ladders reveal that the net charge of ALS-linked superoxide dismutase can be different in sign and magnitude from predicted values. |
| Q58108987 | Quantum chemical and molecular mechanics studies on the assessment of interactions between resveratrol and mutant SOD1 (G93A) protein |
| Q91590333 | ROS-related mitochondrial dysfunction in skeletal muscle of an ALS mouse model during the disease progression |
| Q36145199 | S-Nitrosoglutathione Reductase Plays Opposite Roles in SH-SY5Y Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis |
| Q35961208 | SOD1 aggregation in ALS mice shows simplistic test tube behavior |
| Q41634741 | Spinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells. |
| Q64950127 | Structural Properties and Interaction Partners of Familial ALS-Associated SOD1 Mutants. |
| Q35377964 | Structural and kinetic analysis of protein-aggregate strains in vivo using binary epitope mapping |
| Q35049047 | Superoxide dismutases and superoxide reductases |
| Q41668065 | Susceptibility of Mutant SOD1 to Form a Destabilized Monomer Predicts Cellular Aggregation and Toxicity but Not In vitro Aggregation Propensity. |
| Q46426709 | Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis |
| Q91419222 | The biophysics of superoxide dismutase-1 and amyotrophic lateral sclerosis |
| Q39437151 | The relevance of contact-independent cell-to-cell transfer of TDP-43 and SOD1 in amyotrophic lateral sclerosis |
| Q99410157 | Trifluoroethanol Partially Unfolds G93A SOD1 Leading to Protein Aggregation: A Study by Native Mass Spectrometry and FPOP Protein Footprinting |
| Q57805726 | Tryptophan 32-mediated SOD1 aggregation is attenuated by pyrimidine-like compounds in living cells |
| Q93061331 | Tryptophan residue 32 in human Cu-Zn superoxide dismutase modulates prion-like propagation and strain selection |
| Q36323485 | Uncovering the Mechanism of Aggregation of Human Transthyretin |
| Q51263493 | X-Ray Structural Study of Amyloid-Like Fibrils of Tau Peptides Bound to Small-Molecule Ligands. |
Search more.